AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Viral Hepatitis Policy Meets Practice at the Liver Meeting

Photo of author speaking at meeting

Earlier this month, the “Liver Meeting” – the annual meeting of the American Association for the Study of Liver Diseases (AASLD )– took place in Washington, DC. As part of a session re-capping the major viral hepatitis highlights from the conference, I had the pleasure of sharing with several thousand scientists and healthcare professionals from around…

Viral Hepatitis Action Plan 2012 Progress Report Released

viral_hepatitis_support

In a new report, partners from across the U.S. government have shared an update on progress made during 2012 in implementing the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. This is our second such progress report; a report on the first year of implementing the Action Plan was published last October….

Viral Hepatitis Prevention Coordinators Convene in DC

Drs. Ron Valdiserri, Ellie McCance-Katz, and John Ward dicussing federal viral hepatitis initiatives with Viral Hepatitis Prevention Coordinators from across the country.

Last week I had the opportunity to discuss the federal response to viral hepatitis with some of our key allies in the states: the CDC-funded Adult Viral Hepatitis Prevention Coordinators who had assembled in Washington, DC for the third National Hepatitis Technical Assistance meeting organized and hosted by the National Alliance of State and Territorial…

Together on the Pathways to Wellness: Recovery and Efforts to Strengthen Viral Hepatitis Services

Ronald Valdiserri

Throughout September’s observance of National Recovery Month, individuals, organizations, and communities across the nation celebrated recovery from mental health issues and addiction challenges. Given the significant role that drug-using behaviors can play in the transmission of viral hepatitis, and the fact that alcohol intake often worsens liver disease among persons with chronic viral hepatitis, National Recovery…

New Media Communication: Communicating about HIV and Viral Hepatitis in Complex Times

Meico Whitlock

Last month, the National Alliance of State and Territorial AIDS Directors  (NASTAD) attended the fourth annual Plain Talk in Complex Times conference  in Arlington, Virginia. This year’s theme was “Communicating in a Time of Change.” The conference was hosted by the MAXIMUS Center for Health Literacy  in collaboration with the American Public Health Association  (APHA) and brought together leaders…

FDA Safety Communication: Reducing the Risk of Hepatitis B Reactivation in Patients Using Two Immune-Suppressing and Anti-Cancer Drugs

FDA

On September 25, 2013, the Food and Drug Administration (FDA) issued a Drug Safety Communication announcing that the FDA has approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) to add new Boxed Warning information about the risk of reactivation of hepatitis B virus (HBV) infection. The…

Update on Renewal of Viral Hepatitis Action Plan

VHAP Meeting (cropped)

As we announced this past May, federal partners are working to renew and extend the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis for three more years. Since that announcement, several important activities have been undertaken and I wanted to share this update with readers. To inform the renewal of the plan,…

CMS Invites Public Comment as it Considers National Coverage Determination for HCV Screening Under Medicare

blog.aids.gov

The Centers for Medicare and Medicaid Services (CMS) has initiated a National Coverage Determination (NCD) process for screening for hepatitis C virus (HCV) in adults. An NCD is a national policy statement granting, limiting, or excluding Medicare coverage for a specific medical item or service. CMS is allowed to add coverage of “additional preventive services”…